litlas
Log inCreate account

Jens Meiler

Active 2000–2026

235
Papers
23,010
Citations
76
h-index
186
i10-index

Citations

Citations per year for Jens Meiler1981: 2 citations1986: 2 citations1989: 1 citations1990: 2 citations1993: 1 citations1995: 1 citations1996: 1 citations1997: 1 citations1998: 2 citations2000: 3 citations2001: 17 citations2002: 24 citations2003: 30 citations2004: 55 citations2005: 66 citations2006: 48 citations2007: 92 citations2008: 122 citations2009: 163 citations2010: 128 citations2011: 165 citations2012: 170 citations2013: 224 citations2014: 218 citations2015: 256 citations2016: 290 citations2017: 253 citations2018: 315 citations2019: 709 citations2020: 889 citations2021: 1,130 citations2022: 926 citations2023: 757 citations2024: 1,268 citations2025: 750 citations2026: 72 citations1982–1985: no citations, so these years are not shown1987–1988: no citations, so these years are not shown1991–1992: no citations, so these years are not shown1994: no citations, so this year is not shown1999: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,495 citing papers, 30% of this breakdownChina: 1,159 citing papers, 10% of this breakdownGermany: 764 citing papers, 6.6% of this breakdownUnited Kingdom: 675 citing papers, 5.8% of this breakdownFrance: 401 citing papers, 3.4% of this breakdownIndia: 392 citing papers, 3.4% of this breakdownSwitzerland: 333 citing papers, 2.9% of this breakdownItaly: 324 citing papers, 2.8% of this breakdownCanada: 290 citing papers, 2.5% of this breakdownJapan: 287 citing papers, 2.5% of this breakdownSpain: 246 citing papers, 2.1% of this breakdownAustralia: 245 citing papers, 2.1% of this breakdown
0%30%Other 25.9%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology47.6%
  • Medicine24.2%
  • Computer Science13.2%
  • Chemistry3.2%
  • Neuroscience3.1%
  • Materials Science2.3%
  • Other6.4%

Topics

  • Protein Structure and Dynamics9.5%
  • Computational Drug Discovery Methods7.3%
  • Enzyme Structure and Function4.1%
  • RNA and protein synthesis mechanisms3.6%
  • SARS-CoV-2 and COVID-19 Research3.3%
  • Receptor Mechanisms and Signaling2.9%
  • Other69.3%

Coauthors

All papers

Open in search
  1. Computational Methods in Drug Discovery

    Authors: Gregory Sliwoski, Sandeepkumar Kothiwale, Jens Meiler, Edward W. Lowe - Pharmacological Reviews 2014 cited by 2,168

  2. Sampling alternative conformational states of transporters and receptors with AlphaFold2

    Authors: Diego del Alamo, Davide Sala, Hassane S. Mchaourab, Jens Meiler - eLife 2022 cited by 537

  3. Macromolecular modeling and design in Rosetta: recent methods and frameworks

    Authors: Julia Koehler Leman, Brian D. Weitzner, Steven M. Lewis, Jared Adolf‐Bryfogle, Nawsad Alam, Rebecca F. Alford, Melanie L. Aprahamian, David Baker, Kyle A. Barlow, Patrick Barth, Benjamin Basanta, Brian J. Bender, Kristin Blacklock, Jaume Bonet, Scott E. Boyken, Phil Bradley, Chris Bystroff, Patrick Conway, Seth Cooper, Bruno E. Correia, Brian Coventry, Rhiju Das, René M. de Jong, Frank DiMaio, Lorna Dsilva, Roland L. Dunbrack, Alexander S. Ford, Brandon Frenz, Darwin Fu, Caleb Geniesse, Lukasz Goldschmidt, Ragul Gowthaman, Jeffrey J. Gray, Dominik Gront, Sharon L. Guffy, Scott Horowitz, Po‐Ssu Huang, Thomas Huber, Timothy M. Jacobs, Jeliazko R. Jeliazkov, David K. Johnson, Kalli Kappel, John Karanicolas, Hamed Khakzad, Karen R. Khar, Sagar D. Khare, Firas Khatib, Alisa Khramushin, Indigo C. King, Robert Kleffner, Brian Koepnick, Tanja Kortemme, Georg Kuenze, Brian Kuhlman, Daisuke Kuroda, Jason W. Labonte, Jason Lai, Gideon Lapidoth, Andrew Leaver‐Fay, Steffen Lindert, Thomas W. Linsky, Nir London, Joseph H. Lubin, Sergey Lyskov, Jack B. Maguire, Lars Malmström, Enrique Marcos, Orly Marcu, Nicholas Marze, Jens Meiler, Rocco Moretti, Vikram Khipple Mulligan, Santrupti Nerli, Christoffer Norn, Shane Ó’Conchúir, Noah Ollikainen, Sergey Ovchinnikov, Michael S. Pacella, Xingjie Pan, Hahnbeom Park, Ryan E. Pavlovicz, Manasi A. Pethe, Brian G. Pierce, Kala Bharath Pilla, Barak Raveh, P. Douglas Renfrew, Shourya S. Roy Burman, Aliza B. Rubenstein, Marion F. Sauer, Andreas Scheck, William R. Schief, Ora Schueler‐Furman, Yuval Sedan, Alexander M. Sevy, Nikolaos G. Sgourakis, Lei Shi, Justin B. Siegel, Daniel‐Adriano Silva, Shannon T. Smith, Yifan Song and 8 more - Nature Methods 2020 cited by 923

  4. Rosetta3

    Authors: Andrew Leaver‐Fay, Michael D. Tyka, Steven M. Lewis, Oliver F. Lange, James Thompson, Ron Jacak, Kristian W. Kaufman, P. Douglas Renfrew, Colin A. Smith, William Sheffler, Ian Davis, Seth Cooper, Adrien Treuille, Daniel J. Mandell, Florian Richter, Yih‐En Andrew Ban, Sarel J. Fleishman, Jacob E. Corn, David E. Kim, Sergey Lyskov, Monica Berrondo, Stuart Mentzer, Zoran Popović, James J. Havranek, John Karanicolas, Rhiju Das, Jens Meiler, Tanja Kortemme, Jeffrey J. Gray, Brian Kuhlman, David Baker, Philip Bradley - Methods in enzymology on CD-ROM/Methods in enzymology 2010 cited by 2,008

  5. RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite

    Authors: Sarel J. Fleishman, Andrew Leaver‐Fay, Jacob E. Corn, Eva‐Maria Strauch, Sagar D. Khare, Nobuyasu Koga, J. R. Ashworth, Paul Murphy, Florian Richter, Gordon Lemmon, Jens Meiler, David Baker - PLoS ONE 2011 cited by 716

  6. Modeling conformational states of proteins with AlphaFold

    Authors: Davide Sala, Felipe Engelberger, Hassane S. Mchaourab, Jens Meiler - Current Opinion in Structural Biology 2023 cited by 189

  7. Potently neutralizing and protective human antibodies against SARS-CoV-2

    Authors: Seth J. Zost, Pavlo Gilchuk, James Brett Case, Elad Binshtein, Rita E. Chen, Joseph P. Nkolola, Alexandra Schäfer, Joseph X. Reidy, Andrew Trivette, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, David R. Martinez, Lauren E. Williamson, Elaine C. Chen, Taylor Jones, Samuel B. Day, Luke Myers, Ahmed O. Hassan, Natasha M. Kafai, Emma S. Winkler, Julie M. Fox, Swathi Shrihari, Benjamin K. Mueller, Jens Meiler, Abishek Chandrashekar, Noe B. Mercado, James J. Steinhardt, Kuishu Ren, Yueh–Ming Loo, Nicole L. Kallewaard, Broc T. McCune, Shamus P. Keeler, Michael J. Holtzman, Dan H. Barouch, Lisa E. Gralinski, Ralph S. Baric, Larissa B. Thackray, Michael Diamond, Robert H. Carnahan, James E. Crowe - Nature 2020 cited by 1,201

  8. Solvent accessible surface area approximations for rapid and accurate protein structure prediction

    Authors: Elizabeth Durham, Brent M. Dorr, Nils Woetzel, René Staritzbichler, Jens Meiler - Journal of Molecular Modeling 2009 cited by 462

  9. Benchmarking AlphaFold2 on peptide structure prediction

    Authors: Eli Fritz McDonald, Taylor Jones, Lars Plate, Jens Meiler, Alican Gulsevin - Structure 2022 cited by 136

  10. ROSETTALIGAND: Protein–small molecule docking with full side‐chain flexibility

    Authors: Jens Meiler, David Baker - Proteins Structure Function and Bioinformatics 2006 cited by 517

  11. Biasing AlphaFold2 to predict GPCRs and kinases with user-defined functional or structural properties

    Authors: Davide Sala, Peter W. Hildebrand, Jens Meiler - Frontiers in Molecular Biosciences 2023 cited by 86

  12. Generation and evaluation of dimension-reduced amino acid parameter representations by artificial neural networks

    Authors: Jens Meiler, Anita Zeidler, Felix Schm�schke, Michael M�ller - Journal of Molecular Modeling 2001 cited by 296

  13. Recent Advances in Automated Structure-Based De Novo Drug Design

    Authors: Yidan Tang, Rocco Moretti, Jens Meiler - Journal of Chemical Information and Modeling, J. Chem. Inf. Model. 2024 cited by 67

  14. Molecular architecture of the human caveolin-1 complex

    Authors: Jason C. Porta, Bing Han, Alican Gulsevin, Jeong Min Chung, Yelena Peskova, Sarah M. Connolly, Hassane S. Mchaourab, Jens Meiler, Erkan Karakaş, Anne K. Kenworthy, Melanie D. Ohi - Science Advances 2022 cited by 124

  15. Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity

    Authors: Ariella B. Hanker, Benjamin P. Brown, Jens Meiler, Arnaldo Marín, Harikrishna Sekar Jayanthan, Dan Ye, Chang‐Ching Lin, Hiroaki Akamatsu, Kyung‐min Lee, Sumanta Chatterjee, Dhivya R. Sudhan, Alberto Servetto, Monica Red Brewer, James P. Koch, Jonathan H. Sheehan, Jie He, Alshad S. Lalani, Carlos L. Arteaga - Cancer Cell 2021 cited by 99

  16. Practically Useful: What the R osetta Protein Modeling Suite Can Do for You

    Authors: Kristian Kaufmann, Gordon Lemmon, Samuel DeLuca, Jonathan H. Sheehan, Jens Meiler - Biochemistry 2010 cited by 409

  17. Recognition Dynamics Up to Microseconds Revealed from an RDC-Derived Ubiquitin Ensemble in Solution

    Authors: Oliver F. Lange, Nils‐Alexander Lakomek, Christophe Farès, Gunnar F. Schröder, Korvin F. A. Walter, Stefan Becker, Jens Meiler, Helmut Grubmüller, Christian Griesinger, Bert L. de Groot - Science 2008 cited by 1,064

  18. Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator

    Authors: Huixian Wu, Chong Wang, Karen J. Gregory, Gye Won Han, Hyekyung P. Cho, Yan Xia, Colleen M. Niswender, Vsevolod Katritch, Jens Meiler, Vadim Cherezov, P. Jeffrey Conn, Raymond C. Stevens - Science 2014 cited by 550

  19. Fully Flexible Docking of Medium Sized Ligand Libraries with RosettaLigand

    Authors: Samuel DeLuca, Karen R. Khar, Jens Meiler - PLoS ONE 2015 cited by 159

  20. New algorithms and an in silico benchmark for computational enzyme design

    Authors: Alexandre Zanghellini, Lin Jiang, Andrew M. Wollacott, Gong Cheng, Jens Meiler, Eric A. Althoff, Daniela Röthlisberger, David Baker - Protein Science 2006 cited by 365

  21. Protocols for Molecular Modeling with Rosetta3 and RosettaScripts

    Authors: Brian J. Bender, Alberto Cisneros, Amanda M. Duran, Jessica A. Finn, Darwin Fu, Alyssa D. Lokits, Benjamin K. Mueller, Amandeep K. Sangha, Marion F. Sauer, Alexander M. Sevy, Gregory Sliwoski, Jonathan H. Sheehan, Frank DiMaio, Jens Meiler, Rocco Moretti - Biochemistry 2016 cited by 219

  22. Rosetta Ligand Docking with Flexible XML Protocols

    Authors: Gordon Lemmon, Jens Meiler - Methods in molecular biology 2011 cited by 195

  23. Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design

    Authors: Clara T. Schoeder, Samuel Schmitz, Jared Adolf‐Bryfogle, Alexander M. Sevy, Jessica A. Finn, Marion F. Sauer, Nina G. Bozhanova, Benjamin K. Mueller, Amandeep K. Sangha, Jaume Bonet, Jonathan H. Sheehan, Georg Kuenze, Brennica Marlow, Shannon T. Smith, Hope Woods, Brian J. Bender, Cristina E. Martina, Diego del Alamo, Pranav Kodali, Alican Gulsevin, William R. Schief, Bruno E. Correia, James E. Crowe, Jens Meiler, Rocco Moretti - Biochemistry 2021 cited by 62

  24. On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation

    Authors: Benjamin P. Brown, Yunkai Zhang, David Westover, Yingjun Yan, Huan Qiao, Vincent Huang, Zhenfang Du, Jarrod A. Smith, Jeffrey S. Ross, Vincent A. Miller, Siraj M. Ali, Lyudmila Bazhenova, Alexa B. Schrock, Jens Meiler, Christine M. Lovly - Clinical Cancer Research 2019 cited by 107